Viewing Study NCT04284033


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-31 @ 7:19 PM
Study NCT ID: NCT04284033
Status: WITHDRAWN
Last Update Posted: 2021-09-02
First Post: 2020-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Extended Wear Infusion Set With 670G Hybrid Closed-Loop Therapy
Sponsor: Stanford University
Organization:

Study Overview

Official Title: Evaluation of Extended Wear Infusion Set With 670G Hybrid Closed-Loop Therapy
Status: WITHDRAWN
Status Verified Date: 2021-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Change of sponsor and trial design
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a randomized trial to determine if an extended wear infusion set can be worn for up to 7 days with a hybrid closed-loop system in adult with Type 1 Diabetes
Detailed Description: This study will compare use of a standard infusion set with an extended wear infusion set. Subjects will be asked to wear both types of sets twice for up to 7 days, alternating wear of set type over 4 weeks. The order of infusion set wear will be randomized with the first set wear. The investigators aim to see whether there is a benefit to using an extended wear infusion set.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: